Modulation of bone morphogenic protein signalling alters numbers of astrocytes and oligodendroglia in the subventricular zone during cuprizone-induced demyelination-Reference-Cited by-同舟云学术

Modulation of bone morphogenic protein signalling alters numbers of astrocytes and oligodendroglia in the subventricular zone during cuprizone-induced demyelination

Published:2010-08-19 Issue:1 Volume:115 Page:11-22
ISSN:0022-3042
Container-title:Journal of Neurochemistry
language:en
Short-container-title:

Author:

Cate Holly S.,Sabo Jennifer K.,Merlo Daniel,Kemper Dennis,Aumann Tim D.,Robinson Julien,Merson Toby D.,Emery Ben,Perreau Victoria M.,Kilpatrick Trevor J.

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience,Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1471-4159.2010.06660.x/fullpdf

Reference49 articles.

1. Bone morphogenetic proteins 4, 6, and 7 are up-regulated in mouse spinal cord during experimental autoimmune encephalomyelitis;Ara;J. Neurosci. Res.,2008

2. TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination;Arnett;Nat. Neurosci.,2001

3. Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion;Barnett;Ann. Neurol.,2004

4. Gas6 deficiency increases oligodendrocyte loss and microglial activation in response to cuprizone-induced demyelination;Binder;J. Neurosci.,2008

5. The origin of remyelinating cells in the central nervous system;Blakemore;J. Neuroimmunol.,1999

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A New Acquaintance of Oligodendrocyte Precursor Cells in the Central Nervous System;Neuroscience Bulletin;2024-07-23

2. Astrocytes: Lessons Learned from the Cuprizone Model;International Journal of Molecular Sciences;2023-11-16

3. Endogenous Neural Stem Cell Mediated Oligodendrogenesis in the Adult Mammalian Brain;Cells;2022-07-02

4. Astrocyte and Oligodendrocyte Responses From the Subventricular Zone After Injury;Frontiers in Cellular Neuroscience;2021-12-24

5. Elezanumab, a clinical stage human monoclonal antibody that selectively targets repulsive guidance molecule A to promote neuroregeneration and neuroprotection in neuronal injury and demyelination models;Neurobiology of Disease;2021-11